Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Receives Average Rating of “Hold” from Brokerages

Shares of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC – Get Rating) have received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $8.10.

A number of research analysts have issued reports on the company. StockNews.com upgraded Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a research note on Thursday, October 20th. Piper Sandler reduced their price objective on Tabula Rasa HealthCare from $6.00 to $4.00 and set a “neutral” rating for the company in a research note on Monday, November 7th.

Tabula Rasa HealthCare Trading Up 3.3 %

Shares of Tabula Rasa HealthCare stock opened at $6.33 on Wednesday. The stock has a fifty day simple moving average of $4.60 and a 200 day simple moving average of $4.38. Tabula Rasa HealthCare has a 12-month low of $2.09 and a 12-month high of $13.07. The company has a market capitalization of $171.69 million, a P/E ratio of -1.09 and a beta of 1.58.

Tabula Rasa HealthCare (NASDAQ:TRHC – Get Rating) last announced its quarterly earnings results on Thursday, November 3rd. The company reported ($0.94) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.78). Tabula Rasa HealthCare had a negative return on equity of 472.90% and a negative net margin of 46.03%. The company had revenue of $77.10 million for the quarter, compared to the consensus estimate of $73.68 million. On average, analysts predict that Tabula Rasa HealthCare will post -2.11 EPS for the current year.

Insider Activity

In other news, Director Michael J. Purcell sold 10,000 shares of the company’s stock in a transaction on Friday, December 9th. The stock was sold at an average price of $4.26, for a total transaction of $42,600.00. Following the transaction, the director now owns 88,514 shares of the company’s stock, valued at approximately $377,069.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CFO Thomas Cancro acquired 11,500 shares of the company’s stock in a transaction that occurred on Monday, December 12th. The shares were acquired at an average price of $4.34 per share, with a total value of $49,910.00. Following the acquisition, the chief financial officer now owns 211,500 shares of the company’s stock, valued at approximately $917,910. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Michael J. Purcell sold 10,000 shares of the stock in a transaction dated Friday, December 9th. The stock was sold at an average price of $4.26, for a total value of $42,600.00. Following the sale, the director now directly owns 88,514 shares in the company, valued at approximately $377,069.64. The disclosure for this sale can be found here. Insiders own 7.25% of the company’s stock.

Institutional Trading of Tabula Rasa HealthCare

A number of institutional investors have recently added to or reduced their stakes in TRHC. Teachers Retirement System of The State of Kentucky purchased a new stake in Tabula Rasa HealthCare during the 3rd quarter worth about $25,000. Delphia USA Inc. lifted its holdings in Tabula Rasa HealthCare by 27.5% during the 2nd quarter. Delphia USA Inc. now owns 13,851 shares of the company’s stock worth $36,000 after purchasing an additional 2,984 shares in the last quarter. SG Americas Securities LLC purchased a new stake in Tabula Rasa HealthCare during the 2nd quarter worth about $44,000. Creative Planning purchased a new stake in Tabula Rasa HealthCare during the 2nd quarter worth about $47,000. Finally, Eagle Asset Management Inc. lifted its holdings in Tabula Rasa HealthCare by 27.8% during the 2nd quarter. Eagle Asset Management Inc. now owns 20,402 shares of the company’s stock worth $52,000 after purchasing an additional 4,434 shares in the last quarter. Hedge funds and other institutional investors own 60.90% of the company’s stock.

Tabula Rasa HealthCare Company Profile

(Get Rating)

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems.